Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating YYD601 for non-erosive reflux disease has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• YYD601

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED